A robust screening assay forms the foundation of reliable high-throughput screening (HTS), directly influencing data quality, hit identification, and downstream decision-making. In drug discovery and ...
Serum amyloid A (SAA) is an acute-phase protein widely used as a biomarker for inflammation, infection, and disease monitoring. Accurate laboratory measurement of SAA is essential for clinical ...
This poster was originally authored by John Vincent, Matthew Burnham, Gerrit Daubner, and Martin Main of the Medicines Discovery Catapult. It was presented at ELRIG Drug Discovery 2023. Methods to ...
Friends of Cancer Research initiated a research partnership, inviting HRD assay developers to participate in two blinded analyses. In the first, 11 assay developers reported HRD status for the Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results